Table 1 Demographics of drug-resistant epileptic patient according to the serum concentration of GluR3B antibodies. Notes: serum concentration of GluR3B antibodies: group A ≥ 0.335 OD; group B < 0.335 OD

Age (years)

35.0 ± 15.8

29.2 ± 13.6

Gender (M,%)

21.0 (58.5)

17.0 (60.7)

Epilepsy duration, y

[M (P₂₅,P₇₅)]

10.0 (2.0,18.5)

4.5 (0.78,108)

Age at first seizure, y

[M (P₂₅,P₇₅)]

18.0 (13.0, 37.5)

19.5 (13.0, 32.8)

Abnormal EEG (n, %)

35.0 (97.2)

26.0 (92.9)

Abnormal MRI (n, %)

21.0 (58.3)

21.0 (75.0)

Number of AEDs

2.4 ± 0.5

2.3 ± 0.6